Transformation of xanthohumol by Aspergillus ochraceus

Journal of Basic Microbiology

Volumn 54, Issue 1, 2014, Pages 66-71

  Tronina, Tomasz ^a   Bartmańska, Agnieszka ^a   Poplłoński, Jaroslław ^a   Huszcza, Ewa ^a  

^a WROC AW UNIVERSITY OF ENVIRONMENTAL AND LIFE SCIENCES   (Poland)

Author keywords

Antioxidants; Aspergillus ochraceus; Aurone; Biotransformation; Flavonoid; Xanthohumol

Indexed keywords

ASPERGILLUS OCHRACEUS; HUMULUS;

2'-(2''-HYDROXYISOPROPYL)-DIHYDROFURANO(4',5'-6,7)-3′,4′-DIHYDROXY-4-METHOXYAURONE; 2' (2'' HYDROXYISOPROPYL) DIHYDROFURANO(4',5' 6,7) 3′,4′ DIHYDROXY 4 METHOXYAURONE; ANTIOXIDANT; AURONE; BENZOFURAN DERIVATIVE; BENZYLIDENE DERIVATIVE; FLAVONOID; PROPIOPHENONE DERIVATIVE; XANTHOHUMOL;

ARTICLE; ASPERGILLUS OCHRACEUS; BIOTRANSFORMATION; CHEMISTRY; ISOLATION AND PURIFICATION; METABOLISM;

ANTIOXIDANTS; ASPERGILLUS OCHRACEUS; AURONE; BIOTRANSFORMATION; FLAVONOID; XANTHOHUMOL;

ANTIOXIDANTS; ASPERGILLUS OCHRACEUS; BENZOFURANS; BENZYLIDENE COMPOUNDS; BIOTRANSFORMATION; FLAVONOIDS; PROPIOPHENONES;

EID: 84891559455     PISSN: 0233111X     EISSN: 15214028     Source Type: Journal    
DOI: 10.1002/jobm.201200320     Document Type: Article

References (39)

1. Havsteen, B.H., 2002. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther., 96, 67-202.
2. Colgate, E.C., Miranda, C.L., Stevens, J.F., Bray, T.M. et al., 2007. Xanthohumol, a prenylflavonoid derived from hops induces apoptosis and inhibits NF-κB activation in prostate epithelial cells. Cancer Lett., 246, 201-209.
3. Gerhäuser, C., Alt, A., Heiss, E., Gamal-Eldeen, A. et al., 2002. Cancer chemopreventive activity of xanthohumol, a natural product derived from hop. Mol. Cancer Ther., 1, 959-969.
4. Guerreiro, S., Monteiro, R., Martins, M.J., Calhau, C. et al., 2007. Distinct modulation of alkaline phosphatase isoenzymes by 17β-estradiol and xanthohumol in breast cancer MCF-7 cells. Clin. Biochem., 40, 268-273.
5. Miranda, C.L., Stevens, J.F., Helmrich, A., Henderson, M.C. et al., 1999. Antiproliferative and cytotoxic effects of prenylated flavonoids from hops (Humulus lupulus) in human cancer cell lines. Food Chem. Toxicol., 37, 271-285.
6. Monteghirfo, S., Tosetti, F., Ambrosini, C., Stigliani, S. et al., 2008. Antileukemia effects of xanthohumol in Bcr/Abl-transformed cells involve nuclear factor-κB and p53 modulation. Mol. Cancer Ther., 7, 2692-2702.
7. Vogel, S., Ohmayer, S., Brunner, G., Heilmann, J., 2008. Natural and non-natural prenylated chalcones: synthesis, cytotoxicity and anti-oxidative activity. Bioorg. Med. Chem., 16, 4286-4293.
8. Kac, J., Plazar, J., Mlinaric, A., Zegura, B. et al., 2008. Antimutagenicity of hops (Humulus lupulus L.): bioassay-directed fractionation and isolation of xanthohumol. Phytomedicine, 15, 216-220.
9. Cho, Y.-C., Kim, H.J., Kim, Y.-J., Lee, K.Y. et al., 2008. Differential anti-inflammatory pathway by xanthohumol in IFN-γ and LPS-activated macrophages. Int. Immunopharmacol., 8, 567-573.
10. Cho, Y.-C., You, S.-K., Kim, H.J., Cho, C.-W. et al., 2010. Xanthohumol inhibits IL-12 production and reduces chronic allergic contact dermatitis. Int. Immunopharmacol., 10, 556-561.
11. Dorn, C., Kraus, B., Motyl, M., Weiss, T.S. et al., 2010. Xanthohumol, a chalcon derived from hops, inhibits hepatic inflammation and fibrosis. Mol. Nutr. Food Res., 54, 205-213.
12. Buckwold, V.E., Wilson, R.J.H., Nalca, A., Beer, B.B. et al., 2004. Antiviral activity of hop constituents against a series of DNA and RNA viruses. Antiviral Res., 61, 57-62.
13. Wang, Q., Ding, Z.-H., Liu, J.-K., Zheng, Y.-T., 2004. Xanthohumol, a novel anti-HIV-1 agent purified from Hops Humulus lupulus. Antiviral Res., 64, 189-194.
14. Tobe, H., Kitamura K., Komiyama, O., 1997. Pharmaceutical composition for treating osteoporosis. Patent US 5679716.
15. Herath, H.M.W., Ferreira, D., Khan, I.A., 2003. Microbial transformation of xanthohumol. Phytochemistry, 62, 673-677.
16. Herath, H.M.W., Ferreira, D., Khan, S.I., Khan, I.A., 2003. Identification and biological activity of microbial metabolites of xanthohumol. Chem. Pharm. Bull., 51, 1237-1240.
17. Huszcza, E., Bartmańska, A., Tronina, T., 2008. Glycosylation of xanthohumol by fungi. Z. Naturforsch. [C], 63, 557-560.
18. Kim, H.J., Lee, I.-S., 2006. Microbial metabolism of the prenylated chalcone xanthohumol. J. Nat. Prod., 69, 1522-1524.
19. Sanchez-Gonzalez, M., Rosazza, J.P.N., 2004. Microbial transformations of chalcones: hydroxylation, O-demethylation, and cyclization to flavanones. J. Nat. Prod., 67, 553-558.
20. Nakayama, T., 2002. Enzymology of aurone biosynthesis. J. Biosci. Bioeng., 94, 487-491.
21. Beney, C., Mariotte, A.-M., Boumendjel, A., 2001. An efficient synthesis of 4, 6-dimethoxyaurones. Heterocycles, 55, 967-972.
22. Thakkar, K., Cushman, M., 1995. A novel oxidative cyclization of 2′-hydroxychalcones to 4, 5-dialkoxyaurones by thallium(III) nitrate. J. Org. Chem., 60, 6499-6510.
23. Boumendjel, A., 2003. Aurones: a subclass of flavones with promising biological potential. Curr. Med. Chem., 10, 2621-2630.
24. Ono, M., Maya, Y., Haratake, M., Ito, K. et al., 2007. Aurones serve as probes of β-amyloid plaques in Alzheimer's disease. Biochem. Biophys. Res. Commun., 361, 116-121.
25. Okombi, S., Rival, D., Bonnet, S., Mariotte, A.M. et al., 2006. Discovery of benzylidenebenzofuran-3(2H)-one (aurones) as inhibitors of tyrosinase derived from human melanocytes. J. Med. Chem., 49, 329-333.
26. Sim, H.-M., Lee, C.-Y., Ee, P.L.R., Go, M.-L., 2008. Dimethoxyaurones: potent inhibitors of ABCG2 (breast cancer resistance protein). Eur. J. Pharm. Sci., 35, 293-306.
27. Abourashed, E.A., Clark, A.M., Hufford, C.D., 1999. Microbial models of mammalian metabolism of xenobiotics: an upadate. Curr. Med. Chem., 6, 359-374.
28. Smith, R.A., Rosazza, J.P., 1974. Microbial models of mammalian drug metabolism, aromatic hydroxylation. Arch. Biochem. Biophys., 161, 551-558.
29. Stevens, J.F., Ivancic, M., Hsu, V.L., Deinzer, M.L., 1997. Prenylflavonoids from Humulus lupulus. Phytochemistry, 44, 1575-1585.
30. Sharma, O.P., Bhat, T.K., 2009. DPPH antioxidant assay revisited. Food Chem., 113, 1202-1205.
31. Yilmazer, M., Stevens, J.F., Deinzer, M.L., Buhler, D.R., 2001. In vitro biotransformation of xanthohumol, a flavonoid from hops (Humulus lupulus), by rat liver microsomes. Drug Metab. Dispos., 26, 223-231.
32. Nikolic, D., Li, Y., Chadwick, L.R., Pauli, G.F. et al., 2005. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.) by human liver microsomes. J. Mass Spectrom., 40, 289-299.
33. Agrawal, P., Bansal, M., 1989. Carbon-13 NMR of flavonoids, in: Agrawal, P. (Ed.), Studies in Organic Chemistry (Series Edition No. 39), Elsevier, Amsterdam, Netherlands, pp. 236-282.
34. Nookandeh, A., Frank, N., Steiner, F., Ellinger, R. et al., 2004. Xanthohumol metabolites in faeces of rats. Phytochemistry, 65, 561-570.
35. Gaffield, W., 1970. Circular dichroism, optical rotatory dispersion and absolute configuration of flavanones, 3-hydroxyflavanones and their glycosides: determination of aglycone chirality in flavanone glycosides. Tetrahedron, 26, 4093-4108.
36. Sanchez-Gonzalez, M., Rosazza, J.P.N., 2006. Biocatalytic synthesis of butein and sulfuretin by Aspergillus alliaceus. J. Agric. Food Chem., 54, 4646-4650.
37. Nakayama, T., Sato, T., Fukui, Y., Yonekura-Sakakibara, K. et al., 2001. Specificity analysis and mechanism of aurone synthesis catalyzed by aureusidin synthase, a polyphenol oxidase homolog responsible for flower coloration. FEBS Lett., 499, 107-111.
38. Silva, M., Santos, M., Caroço, G., Rocha, R. et al., 2002. Structure-antioxidant activity relationships of flavonoids: a re-examination. Free Radic. Res., 36, 1219-1227.
39. Aniolł, M., Świderska, A., Stompor, M., Zolłnierczyk, A.K., 2012. Antiproliferative activity and synthesis of 8-prenylnaringenin derivatives by demethylation of 7-O- and 4′-O-substituted isoxanthohumols. Med. Chem. Res., 21(12), 4230-4238.